MENU
+Compare
ENTA
Stock ticker: NASDAQ
AS OF
Dec 26, 10:35 AM (EDT)
Price
$16.53
Change
-$0.07 (-0.42%)
Capitalization
479.12M

ENTA Enanta Pharmaceuticals Forecast, Technical & Fundamental Analysis

Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications... Show more

Industry: #Biotechnology
ENTA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for ENTA with price predictions
Dec 24, 2025

Aroon Indicator for ENTA shows an upward move is likely

ENTA's Aroon Indicator triggered a bullish signal on December 24, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 182 similar instances where the Aroon Indicator showed a similar pattern. In of the 182 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for ENTA just turned positive on December 22, 2025. Looking at past instances where ENTA's MACD turned positive, the stock continued to rise in of 54 cases over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where ENTA advanced for three days, in of 284 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ENTA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ENTA broke above its upper Bollinger Band on December 24, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ENTA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.402) is normal, around the industry mean (26.541). P/E Ratio (0.000) is within average values for comparable stocks, (51.479). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.873). Dividend Yield (0.000) settles around the average of (0.049) among similar stocks. P/S Ratio (5.423) is also within normal values, averaging (311.015).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ENTA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
ENTA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

ENTA is expected to report earnings to fall 10.55% to -77 cents per share on February 09

Enanta Pharmaceuticals ENTA Stock Earnings Reports
Q4'25
Est.
$-0.78
Q3'25
Beat
by $0.14
Q2'25
Missed
by $0.01
Q1'25
Beat
by $0.10
Q4'24
Beat
by $0.22
The last earnings report on November 17 showed earnings per share of -87 cents, beating the estimate of -100 cents. With 292.15K shares outstanding, the current market capitalization sits at 479.12M.
A.I. Advisor
published General Information

General Information

a developer of drugs and other pharmaceuticals products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
500 Arsenal Street
Phone
+1 617 607-0800
Employees
145
Web
https://www.enanta.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RCOCX43.800.17
+0.39%
Victory RS Large Cap Alpha C
IRLSX86.760.19
+0.22%
Voya Russell Large Cap Growth Idx Port S
MSHMX13.370.03
+0.22%
Morgan Stanley Inst Permanence I
WHGLX11.94N/A
N/A
Westwood Quality Value Fund Inst
FEGOX53.28-0.24
-0.45%
First Eagle Gold C

ENTA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ENTA has been loosely correlated with MRUS. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if ENTA jumps, then MRUS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENTA
1D Price
Change %
ENTA100%
+5.67%
MRUS - ENTA
50%
Loosely correlated
+0.01%
NEVPF - ENTA
44%
Loosely correlated
N/A
ORKA - ENTA
38%
Loosely correlated
+1.29%
VRDN - ENTA
35%
Loosely correlated
+0.53%
ANAB - ENTA
34%
Loosely correlated
-0.06%
More